Production (Stage)
enGene Holdings Inc.
ENGN
$3.33
$0.082.46%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 24.95M | 25.49M | 23.98M | 22.57M | 19.71M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 87.95M | 78.14M | 62.30M | 55.28M | 44.77M |
Operating Income | -87.95M | -78.14M | -62.30M | -55.28M | -44.77M |
Income Before Tax | -79.63M | -69.02M | -55.16M | -122.36M | -112.90M |
Income Tax Expenses | 248.00K | 29.00K | -19.00K | -21.00K | 8.00K |
Earnings from Continuing Operations | -79.88 | -69.05 | -55.14 | -122.34 | -112.91 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -79.88M | -69.05M | -55.14M | -122.34M | -112.91M |
EBIT | -87.95M | -78.14M | -62.30M | -55.28M | -44.77M |
EBITDA | -87.64M | -77.85M | -62.03M | -55.00M | -44.52M |
EPS Basic | -1.65 | -1.53 | -1.51 | -119.09 | -127.31 |
Normalized Basic EPS | -1.03 | -0.95 | -0.93 | -23.75 | -25.13 |
EPS Diluted | -1.65 | -1.53 | -1.51 | -119.09 | -127.31 |
Normalized Diluted EPS | -1.03 | -0.95 | -0.93 | -23.75 | -25.13 |
Average Basic Shares Outstanding | 190.60M | 179.02M | 151.25M | 107.52M | 64.05M |
Average Diluted Shares Outstanding | 190.60M | 179.02M | 151.25M | 107.52M | 64.05M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |